ANDREW BROWER: Open Payments
NPI 1942764907 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,874 in 91 payments from 15 companies in 2025. Trend: 2023 $1,180 · 2024 $1,822 · 2025 $1,874
Food & beverage: $1,874
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 17 | $337 |
| Calliditas Therapeutics US Inc. | 12 | $309 |
| Fresenius USA Marketing, Inc. | 10 | $186 |
| Travere Therapeutics, Inc. | 9 | $176 |
| AstraZeneca Pharmaceuticals LP | 7 | $145 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $136 |
| Otsuka America Pharmaceutical, Inc. | 6 | $134 |
| AKEBIA THERAPEUTICS INC | 6 | $118 |
| Novartis Pharmaceuticals Corporation | 6 | $115 |
| Vifor Pharma, Inc. | 3 | $83 |
Products named: TARPEYO, KRYSTEXXA, VELPHORO, FARXIGA, TAVNEOS, Kerendia, JYNARQUE, Vafseo.
Industry payments across TN — which companies pay providers there.
